Ausgabe 5/2022
Supplement: Evolving Roles of Optimal Medical Therapy and PCI in Chronic Coronary Syndrome Patients with Stable Angina (pages 1005 - 1045)
Inhalt (24 Artikel)
Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice
Marie Vincenti, Charlotte Farah, Pascal Amedro, Valerie Scheuermann, Alain Lacampagne, Olivier Cazorla
Mirabegron Ameliorated Atherosclerosis of ApoE−/− Mice in Chronic Intermittent Hypoxia but Not in Normoxia
Yue Wang, Yue Wang, Hong-feng Jiang, Hai-ming Dang, Meng-ru Liu, Xin-yan Liu, Yang Yu, Jiang Xie, Xiao-jun Zhan, Hui-na Zhang, Xiao-fan Wu
The IL-6/STAT Signaling Pathway and PPARα Are Involved in Mediating the Dose-Dependent Cardioprotective Effects of Fenofibrate in 5-Fluorouracil-Induced Cardiotoxicity
Marwa M. M. Refaie, Sayed Shehata, Asmaa M. A. Bayoumi, Nashwa Fathy Gamal El-Tahawy, Walaa Yehia Abdelzaher
Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus
Yochai Birnbaum, Huan Chen, Dat Tran, Sven Nylander, Yumei Ye
Morphine Prevents Ischemia/Reperfusion-Induced Myocardial Mitochondrial Damage by Activating δ-opioid Receptor/EGFR/ROS Pathway
Jingman Xu, Xiyun Bian, Huanhuan Zhao, Yujie Sun, Yanyi Tian, Xiaodong Li, Wei Tian
Effect of Paclitaxel-Coated Balloon Angioplasty on Side Branch Lesion and Cardiovascular Outcomes in Patients with De Novo True Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
Youmei Li, Qi Mao, Huanyun Liu, Denglu Zhou, Jianhua Zhao
Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data
Stella Talic, Clara Marquina, Richard Ofori-Asenso, Marjana Petrova, Danny Liew, Alice J. Owen, Sean Lybrand, David Thomson, Jenni Ilomaki, Ella Zomer, Zanfina Ademi
An Adapted Neural-Fuzzy Inference System Model Using Preprocessed Balance Data to Improve the Predictive Accuracy of Warfarin Maintenance Dosing in Patients After Heart Valve Replacement
Zhi-Chun Gu, Shou-Rui Huang, Li Dong, Qin Zhou, Jing Wang, Bo Fu, Jin Chen
Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants
Songnan Wen, Cristina Pislaru, Kristi H. Monahan, Stephanie M. Barnes, David O. Hodge, Douglas L. Packer, Sorin V. Pislaru, Samuel J. Asirvatham
Effects of Major Antihypertensive Drug Classes on Erectile Function: a Network Meta-analysis
Ioannis T. Farmakis, Nikolaos Pyrgidis, Ioannis Doundoulakis, Ioannis Mykoniatis, Evangelos Akrivos, George Giannakoulas
Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance
Yee Soo Kim, Simerjeet Brar, Natalie D’Albo, Amit Dey, Sachin Shah, Sarju Ganatra, Sourbha S. Dani
RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
Sean M. Davidson, Kishal Lukhna, Diana A. Gorog, Alan D. Salama, Alejandro Rosell Castillo, Sara Giesz, Pelin Golforoush, Siavash Beikoghli Kalkhoran, Sandrine Lecour, Aqeela Imamdin, Helison R. P. do Carmo, Ticiane Gonçalez Bovi, Mauricio W. Perroud Jr, Mpiko Ntsekhe, Andrei C. Sposito, Derek M. Yellon
Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
Sean M. Davidson, Kishal Lukhna, Diana A. Gorog, Alan D. Salama, Alejandro Rosell Castillo, Sara Giesz, Pelin Golforoush, Siavash Beikoghli Kalkhoran, Sandrine Lecour, Aqeela Imamdin, Helison R. P. do Carmo, Ticiane Gonçalez Bovi, Mauricio W. Perroud Jr, Mpiko Ntsekhe, Andrei C. Sposito, Derek M. Yellon
Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell–Derived Microvesicles to Repair the Ischemic Heart
Gemma Vilahur, Phuong Hue Nguyen, Lina Badimon
Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis
Ioannis Doundoulakis, Maria Gavriilaki, Dimitris Tsiachris, Petros Arsenos, Christos-Konstantinos Antoniou, Smaro Dimou, Stergios Soulaidopoulos, Ioannis Farmakis, Evangelos Akrivos, Panagiotis Stoiloudis, Konstantinos Notas, Vasilios K. Kimiskidis, George Giannakoulas, Stylianos Paraskevaidis, Konstantinos A. Gatzoulis, Konstantinos Tsioufis
Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease
Waleed AlHabeeb, Sanaa Mrabeti, Ahmed Adel Ibrahim Abdelsalam
Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants
Robert Benamouzig, Maxime Guenoun, David Deutsch, Laurent Fauchier
Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis
Yuttana Wongsalap, Supakorn Ungsriwong, Wanalee Kumtep, Surasak Saokaew, Vichai Senthong, Kirati Kengkla
Opioids in Acute Coronary Syndromes: Friend or Foe?
Maryna V. Basalay, Derek M. Yellon, Sean M. Davidson
Evolving Roles of Optimal Medical Therapy and PCI in Chronic Coronary Syndrome Patients with Stable Angina: Introduction
William E. Boden, Juan Carlos Kaski
Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding
Alexandra N Nowbar, Darrel P Francis, Rasha K Al-Lamee
The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist’s Perspective
Kreton Mavromatis, Anthony Gershlick
What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?
Colin Berry, Andrew J. Morrow, Mario Marzilli, Carl J. Pepine
Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA
David L. Brown